Firebrick Pharma Ltd | ABN 64 157 765 896 | L14, 333 Collins St. Melbourne, VIC, 3000, Australia P: 1300 301 874 | W: firebrickpharma.com 19 October 2026 ASX Release Notice under Section 708A of the Corporations Act This notice is given by Firebrick Pharma Limited (Issuer or Company) (ASX:FRE)...